Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption of antiretroviral therapy-Reference-Cited by-同舟云学术

Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption of antiretroviral therapy

Published:2008-06-19 Issue:10 Volume:22 Page:1153-1161
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Papasavvas Emmanouil,Azzoni Livio,Pistilli Maxwell,Hancock Aidan,Reynolds Griffin,Gallo Cecile,Ondercin Joe,Kostman Jay R,Mounzer Karam,Shull Jane,Montaner Luis J

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference46 articles.

1. Structured treatment interruptions for the management of HIV infection;Lori;JAMA,2001

2. Structured treatment interruptions to control HIV-1 and limit drug exposure;Montaner;Trends Immunol,2001

3. Randomized, controlled trial of therapy interruption in chronic HIV-1 infection;Papasavvas;PLoS Med,2004

4. CD4+ count-guided interruption of antiretroviral treatment;El-Sadr;N Engl J Med,2006

5. Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients;de Larranaga;Blood Coagul Fibrinolysis,2003

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Infection, Antiretroviral Drugs, and the Vascular Endothelium;Cells;2024-04-12

2. Modalités du traitement de la maladie veineuse thromboembolique du patient VIH par les anticoagulants oraux directs;La Revue de Médecine Interne;2023-04

3. Effect of antiretroviral therapy on decreasing arterial stiffness, metabolic profile, vascular and systemic inflammatory cytokines in treatment-naïve HIV: A one-year prospective study;PLOS ONE;2023-03-17

4. Plasma biomarkers of vascular dysfunction uniquely relate to a vascular-risk profile of neurocognitive deficits in virally-suppressed adults with HIV;Brain, Behavior, & Immunity - Health;2022-12

5. Increased biomarkers of cardiovascular risk in HIV-1 viremic controllers and low persistent inflammation in elite controllers and art-suppressed individuals;Scientific Reports;2022-04-21